Update date
30 Jun 2024
Shareable Research Card
GENETIC TECHNOLOGIES LTD Goodwill
This metric view shows GENETIC TECHNOLOGIES LTD goodwill history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q2 2024
- Latest reported value
- A$1,784,893
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2024
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q2 2024.
- Latest reported value on this page: A$1,784,893.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Goodwill
Latest reported goodwill: A$1,784,893. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q2 2024
SEC-backed company facts were refreshed from filings filed on 30 Sep 2024.
Benchmark Context
How Goodwill compares with peers
GENETIC TECHNOLOGIES LTD sits in the bottom quarter of the current goodwill sample.
Compared with
Compared with 4 companies reporting goodwill in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.1x the current sample midpoint. Goodwill is down about 43% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2022 to 30 Sep 2024.
- Nearby companies in this sample: Neuphoria Therapeutics Inc..
- Current sample position: rank #4 of 4 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
GENETIC TECHNOLOGIES LTD: Goodwill
Latest period: Q2 2024. Period end: 30 Jun 2024. Units: AUD and USD. Frequency: quarterly.
Goodwill is an SEC-reported metric from company XBRL facts.
Metric Snapshot
- Latest value
- A$1,784,893
- Coverage range
- 31 Dec 2021 - 30 Jun 2024
- Fact rows
- 6
What This Metric Tells You
- Shows the reported level of goodwill over 31 Dec 2021 - 30 Jun 2024.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 6 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare This Metric Across Companies
Compare latest available Goodwill levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
GENETIC TECHNOLOGIES LTD appears at rank #4 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | WESTPAC BANKING CORP (webnf) | A$7,433,000,000 | Instant - 30 Sep 2024 | Open WESTPAC BANKING CORP Goodwill |
| 2 | NOVONIX Ltd (nvx) | A$17,373,413 | Instant - 30 Jun 2022 | Open NOVONIX Ltd Goodwill |
| 3 | Neuphoria Therapeutics Inc. (neup) | A$13,084,300 | Instant - 30 Jun 2023 | Open Neuphoria Therapeutics Inc. Goodwill |
| 4 | GENETIC TECHNOLOGIES LTD | A$1,784,893 | Instant - 30 Jun 2024 | Open GENETIC TECHNOLOGIES LTD Goodwill |
Metric Details
- Metric
- Goodwill (Goodwill)
- Taxonomy
- ifrs-full
- Units tracked
- AUD and USD
- Frequency coverage
- quarterly
- History range
- 31 Dec 2021 - 30 Jun 2024
- Facts on this page
- 6
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Goodwill, Quarterly (AUD)
Goodwill, YoY Quarterly Change (%)
Goodwill, Quarterly (USD)
GENETIC TECHNOLOGIES LTD Quarterly Goodwill (AUD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | A$1,784,893 | -A$1,332,000 | -43% | 30 Jun 2024 | 20-F | 30 Sep 2024 | 2024 | FY |
| Q4 2023 | A$1,784,893 | -A$3,694,134 | -67% | 31 Dec 2023 | 6-K | 26 Feb 2024 | ||
| Q2 2023 | A$3,116,893 | -A$1,389,760 | -31% | 30 Jun 2023 | 20-F | 30 Sep 2024 | 2024 | FY |
| Q4 2022 | A$5,479,027 | 31 Dec 2022 | 6-K | 27 Feb 2023 | 2023 | Q2 | ||
| Q2 2022 | A$4,506,653 | 30 Jun 2022 | 20-F | 30 Aug 2023 | 2023 | FY |
GENETIC TECHNOLOGIES LTD Quarterly Goodwill (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2021 | $4,487,459 | 31 Dec 2021 | 6-K | 24 Feb 2022 | 2022 | Q2 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.